| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.26 | 3e-12 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.19 | 3e-10 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-09 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-08 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.27 | 2e-07 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-07 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 4e-07 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.18 | 5e-07 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.16 | 6e-07 |